Patrys Limited (ASX: PAB)
Patrys Limited (ASX: PAB) is a biotech company working on the development of antibody therapies for major market opportunities in the oncology area. Patrys has two technology platforms: IgM monoclonal antibodies and suite of nuclear penetrating antibodies for cancer therapy. www.patrys.com